Journal article
The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials
Abstract
An efficacious COVID-19 vaccine is currently the world's leading research priority. Several nations have indicated that if there is a compelling case for use of a vaccine before it is licensed, they would be prepared to authorise its emergency use or conditional approval on public health grounds. As of Dec 1, 2020, several developers of leading COVID-19 candidate vaccines have indicated that they have applied, or intend to apply, for emergency …
Authors
Singh JA; Upshur REG
Journal
The Lancet Infectious Diseases, Vol. 21, No. 4, pp. e103–e109
Publisher
Elsevier
Publication Date
April 2021
DOI
10.1016/s1473-3099(20)30923-3
ISSN
1473-3099